Literature DB >> 10529517

Successful treatment of chronic graft-versus-host disease with sulfasalazine in allogeneic bone marrow transplantation.

M Okada1, T Okamoto, S Yamada, S Yamada, T Itoh, A Mori, K Saheki, H Takatsuka, H Wada, Y Tamura A, Y Fujimori, Y Takemoto, E Kakishita.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10529517     DOI： 10.1159/000040981

Source DB:  PubMed          Journal:  Acta Haematol        ISSN： 0001-5792            Impact factor:   2.195


× No keyword cloud information.
  3 in total

Review 1.  Intestinal graft-versus-host disease: mechanisms and management.

Authors:  Hiroyuki Takatsuka; Tsuyoshi Iwasaki; Takahiro Okamoto; Eizo Kakishita
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Zinc finger protein A20 protects rats against chronic liver allograft dysfunction.

Authors:  Jie Yang; Ming-Qing Xu; Lu-Nan Yan; Xiao-Bo Chen; Jiao Liu
Journal:  World J Gastroenterol       Date:  2012-07-21       Impact factor: 5.742

3.  Experience with the use of salazosulfapyridine for intractable diarrhea after hematopoietic stem cell transplantation.

Authors:  Naohiko Moriguchi; Sadayuki Isokawa; Atsushi Ando; Hiroshi Miyata
Journal:  Int J Hematol       Date:  2004-12       Impact factor: 2.490
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.